Exelixis (EXEL) Issues Update on Patent Litigation with MSN Laboratories

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/8/2026


Go back to Exelixis (EXEL) Issues Update on Patent Litigation with MSN Laboratories

Exelixis Announces Update on Patent Litigation with MSN Laboratories

January 19, 2023 6:43 PM UTC

ALAMEDA, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) v. MSN Laboratories Private Limited et al. (MSN), Action No. 19-2017 (Consolidated), the U.S. District Court for the District of Delaware ruled in Exelixis favor, rejecting MSNs challenge to the cabozantinib compound patent (U.S. 7,579,473). The District... More